Colorado Hematology Oncology Conference: Emphasis on Precision-Guided Management

Denver, CO US
April 13, 2024

The Colorado Hematology Oncology Conference: Emphasis on Precision-Guided Management is an accredited continuous education to improve the care of cancer patients by educating cancer care providers about precision-guided management in hematology and oncology. Regional and national experts in the field will share comprehensive insights into the actionable molecular variations seen in common cancers. The event's format is tailored to promote active learning, enhance knowledge retention, and encourage practitioners to apply fresh insights into their clinical routines. Through didactics, case-centric discussions, and lively Q&A sessions, attendees can gain clarity, address uncertainties, and interact with hematology and oncology experts. This conference aims to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in precision-guided management in hematology and oncology.  It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care.

Target Audience

  • Hematologists/ Oncologists
  • Oncology Fellows
  • NPs/PAs
  • Pharmacists
  • Nurses
  • Researchers and others

ORGANIZING COMMITTEE

Conference Director:

Binay Shah, MD, MHA - Binaytara Foundation

Conference Chair: 

Chelsea Gawryletz, DO- University of Colorado Health

Manojkumar Bupathi, MD, MS- US Oncology

VENUE INFORMATION

If you are attending this meeting and need to reserve a hotel room, please reserve your room at the link below to take advantage of the discounted group rate of $229 per night plus applicable taxes and fees:

https://www.hyatt.com/en-US/group-booking/DENRD/G-BINA

The deadline to reserve the hotel room is March 22nd

Learning Objectives

  1. Review common molecular abnormalities in various cancers and the optimal timing to test for these abnormalities.
  2. Interpret the findings from next-generation sequencing and other biomarkers that indicate the likelihood of response to specific therapies while also understanding the inherent challenges.
  3. Apply optimal strategies centered on molecular-targeted treatments in the management of patients with cancer.
  4. Summarize emerging research, the mechanism of action, and the significance of new molecular-targeted treatments in managing cancer patients.

GLOBAL ONCOLOGY PROJECT

To learn more about our ongoing project building a 200-bed cancer hospital in Nepal:

Course summary
Available credit: 
  • 6.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 6.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 6.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.
Course opens: 
11/30/2023
Course expires: 
06/28/2024
Event starts: 
04/13/2024 - 8:00am PDT
Event ends: 
04/13/2024 - 4:30pm PDT
Cost:
$150.00

April 13, 2024

All times are listed in Mountain Time (MT)

07:00 AM – 08:00 AM  Registration, Breakfast, & Exhibits


08:00 AM – 08:05 AM  Welcome 

08:05AM  – 08:25 AM  Binaytara Foundation's Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA


08:25 AM – 09:10 AM  Session 1 - Precision Oncology - General Concepts

Moderator: Abdul Rafeh Naqash, MD

08:25 AM – 08:40 AM  Solid Tumor Genomic Testing - Robert Lentz, MD

08:40 AM – 08:55 AM  Liquid Biopsy - Jason Henry, MD

08:55 AM – 09:10 AM  Q and A


09:10 AM – 10:10 AM  Session 2 - GI Oncology

Moderator: Ignacio Garrido-Laguna, MD, PhD, MBA

09:10 AM – 09:25 AM  Keynote Lecture: Precision Guided Management of GI Cancers- Wells Messersmith, MD, FACP, FASCO

09:25 AM – 10:10 AM  Panel Discussion- Sunnie Kim, MD


10:10 AM – 10:30 AM  Break & Exhibits


10:30 AM – 11:30 AM  Session 3 - Breast Cancer

Moderator: Chelsea Gawryletz, DO

10:30 AM – 10:45 AM  Genomics in Breast Cancer- Radhika Acharya-Leon, DO

10:45 AM – 11:30 AM  Panel Discussion- Anosheh Afghahi, MD


11:30 AM – 12:30 PM  Lunch & Exhibits


12:30 – 01:30 PM  Session 4 - GU Oncology

Moderator: Manojkumar Bupathi, MD, MS

12:30 PM – 12:45 PM  Keynote Speech: Recent Advances in Molecular Guided Treatment of GU Malignancies- Elizabeth Kessler, MD

12:45 PM – 01:30 PM  Panel Discussion - Laura Graham, MD


01:30 PM – 02:30 PM  Session 5 - Lung Cancer

Moderator: Tejas Patil, MD

01:30 PM – 01:45 PM  Keynote Speech: Advances in Precision-guided Management of Lung Cancers- Alec Watson, MD, DPhil, FRCPC

01:45 PM – 02:30 PM  Panel Discussion- Lei Deng, MD


02:30 PM – 03:00 PM  Break & Exhibits


03:00 PM – 04:15 PM  Session 6 - Hematology

Moderator: Steven Bair, MD

03:00 PM – 03:15 PM  Multiple Myeloma- Henning Schade, MD

03:15 PM – 03:30 PM  Myeloid Disorders- Christine McMahon, MD

03:30 PM – 03:45 PM  CLL- Michael Tees, MD, MPH

03:45 PM – 04:15 PM  Case-Based Presentation- Steven Bair, MD


04:15 PM – 04:20 PM  Adjourn

Hotel Grand Hyatt Downtown Denver
1750 Welton Street
Denver, CO 80202
United States

If you are attending this meeting and need to reserve a hotel room, please reserve your room at the link below to take advantage of the discounted group rate of $229 per night plus applicable taxes and fees:

https://www.hyatt.com/en-US/group-booking/DENRD/G-BINA

The deadline to reserve the hotel room is March 22nd

IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:

All conflict of interest has been identified and mitigated for individuals in control of contents.

PLANNING COMMITTEE DISCLOSURE STATEMENT:

None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.

 

Course Director(s)

Binay Shah, MD, MHA

has no relevant financial relationships to disclose at this time.
Conference Chair(s)

Manojkumar Bupathi, MD, MS

has no relevant financial relationships to disclose at this time.

Chelsea Gawryletz, DO

has a financial relationship (Professional Services) with Astra Zeneca ;.
has a financial relationship (Professional Services) with Daiichi Sankyo ;.
has a financial relationship (Professional Services) with Gilead;.
has a financial relationship (Professional Services) with SeaGen;.
Speaker/Topic Presenter(s)

Radhika Acharya-Leon

has no relevant financial relationships to disclose at this time.

Jason Henry, M.D./

has no relevant financial relationships to disclose at this time.

Elizabeth Kessler

has a financial relationship (Grant Or Contract) with Janssen;.
has a financial relationship (Grant Or Contract) with Astra Zeneca;.
has a financial relationship (Grant Or Contract) with Merck;.
has a financial relationship (Grant Or Contract) with Bristol Meyer Squibb;.
has a financial relationship (Grant Or Contract) with Astellas;.

Robert Lentz

has a financial relationship (Grant Or Contract) with Merck;.
has a financial relationship (Independent contractor) with Boehringer Ingelheim;.
has a financial relationship (Grant Or Contract) with ALX Oncology;.
has a financial relationship (Grant Or Contract) with EDDC;.
has a financial relationship (Grant Or Contract) with Guardant;.
has a financial relationship (Independent contractor) with Myeloid Therapeutics;.
has a financial relationship (Grant Or Contract) with Lilly;.
has a financial relationship (Independent contractor) with Agenus;.

Christine McMahon, MD

has a financial relationship (Grant Or Contract) with Kura Oncology;.

Wells Messersmith, MD

has a financial relationship (Grant Or Contract) with ALX;.
has a financial relationship (Grant Or Contract) with RasCal;.
has a financial relationship (Grant Or Contract) with Pfizer;.
has a financial relationship (Professional Services) with Criterium;.
has a financial relationship (Professional Services) with Amgen;.

Henning Schade, MD

has no relevant financial relationships to disclose at this time.

Michael Tees, MD, MPH

has no relevant financial relationships to disclose at this time.

Alexander Watson, MD, DPhil, FRCPC

has a financial relationship (Professional Services) with Intellisphere LLC/MJH Life Sciences;.
Case Presenter(s)

Anosheh Afghahi, M.D., M.P.H.

has no relevant financial relationships to disclose at this time.

Steven Bair, MD

has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.

Lei Deng, MD

has a financial relationship (Travel) with MJH Life Sciences;.
has a financial relationship (Other) with MJH Life Sciences;.

Laura Graham, MD

has no relevant financial relationships to disclose at this time.

Sunnie Kim, Sunnie Kim, MD

has a financial relationship (Independent contractor) with Eisai;.
has a financial relationship (Independent contractor) with Astellas;.
has a financial relationship (Independent contractor) with IMAB;.
has a financial relationship (Independent contractor) with DSI;.
has a financial relationship (Grant Or Contract) with Merck;.
has a financial relationship (Independent contractor) with BMS;.
Moderator(s)

Steven Bair, MD

has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.
has no relevant financial relationships to disclose at this time.

Ignacio Garrido-Laguna

has a financial relationship (Grant Or Contract) with Revolution Medicine;.
has a financial relationship (Grant Or Contract) with BMS;.
has a financial relationship (Grant Or Contract) with Pfizer;.
has a financial relationship (Grant Or Contract) with BridgeBio Pharma , Genentech;.
has a financial relationship (Grant Or Contract) with ABM Therapeutics;.
has a financial relationship (Grant Or Contract) with GlaxoSmithKline ;.
has a financial relationship (Grant Or Contract) with Sotio;.
has a financial relationship (Grant Or Contract) with Sumitomo;.
has a financial relationship (Grant Or Contract) with Bayer;.
has a financial relationship (Grant Or Contract) with Genentech;.
has a financial relationship (Grant Or Contract) with Tango Therapeutics;.
has a financial relationship (Grant Or Contract) with Novartis;.
has a financial relationship (Grant Or Contract) with MedImmune;.

Abdul Rafeh Naqash, MD

has no relevant financial relationships to disclose at this time.

Tejas Patil, MD

has a financial relationship (Financial Support) with Mirati;.
has a financial relationship (Grant Or Contract) with EMD Soreno;.
has a financial relationship (Financial Support) with Takeda;.
has a financial relationship (Financial Support) with Janssen;.
has a financial relationship (Financial Support) with Astrazeneca;.
has a financial relationship (Financial Support) with Sanofi;.
has a financial relationship (Grant Or Contract) with Janssen;.

Available Credit

  • 6.00 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 6.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 6.00 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 6.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 6.00 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 6.00 Contact Hours.

If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information

 

Price

Cost:
$150.00
Please login or register to take this course.

POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE: 

All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place. 

The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference.  The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees. 

If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.

Violating this policy will result in a fine equivalent to a general display fee for that conference. 

If your company has purchased an exhibit or sponsorship, please register at the link below to receive the discounted registration fees:

Link to register as an additional rep of a sponsoring company: https://education.binayfoundation.org/industry_registraiton_nocme .

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 
  • If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.